Evaluation of the Adequacy of WHO Revised Dosages of the First-Line Antituberculosis Drugs in Children with Tuberculosis Using Population Pharmacokinetic Modeling and Simulations

Lignende værker

• Evaluation of the Adequacy of the 2010 Revised World Health Organization Recommended Dosages of the First-line Antituberculosis Drugs for Children
  af: Yang, Hongmei, et al.
  Udgivet: (2018)
• Pharmacokinetics of First-Line Antituberculosis Drugs Using WHO Revised Dosage in Children With Tuberculosis With and Without HIV Coinfection
  af: Kwara, Awewura, et al.
  Udgivet: (2016)
• Pharmacokinetics of the First-Line Antituberculosis Drugs in Ghanaian Children with Tuberculosis with or without HIV Coinfection
  af: Antwi, Sampson, et al.
  Udgivet: (2017)
• Effect of Rifampin-Isoniazid-Containing Antituberculosis Therapy on Efavirenz Pharmacokinetics in HIV-Infected Children 3 to 14 Years Old
  af: Kwara, Awewura, et al.
  Udgivet: (2018)
• Population pharmacokinetics of efavirenz in HIV and TB/HIV coinfected children: the significance of genotype-guided dosing
  af: Alghamdi, Wael A, et al.
  Udgivet: (2019)